Taselisib, a selective inhibitor of PIK3CA, is highly...

Gynecologic Oncology 2014 / 11 Vol. 135; Iss. 2

Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo

Lopez, Salvatore, Schwab, Carlton L., Cocco, Emiliano, Bellone, Stefania, Bonazzoli, Elena, English, Diana P., Schwartz, Peter E., Rutherford, Thomas, Angioli, Roberto, Santin, Alessandro D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
135
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2014.08.024
Date:
November, 2014
File:
PDF, 507 KB
english, 2014
Conversion to is in progress
Conversion to is failed